Table 4.

Expression levels of miRNAs targeting i.a. TYMS mRNA in cancer

miRNA	Level†	Cancers‡	References
miR-140-3p	Down	CRC tissues	Chen et al. (2020c)
	Down	CRC tissues, SW480 and HCT116 cell lines	Jiang et al. (2019a)
	Down	Primary tumor tissues of CRC patients	Piepoli et al. (2012)
	Down	Liver metastatic vs none-metastatic CRC	Liu et al. (2021)
	Down	GC tissues and cell lines	Wang et al. (2021a)
	Down	GC tissues and five cell lines	Chen et al. (2021)
	Down	ESCC tissues and five cell lines	Wang et al. (2021d)
	Down	ESCC tissues and five cell lines	Chen et al. (2020d)
	Down	NSCLC (LUAD) tissues and five cell lines (i.a. A549)	Wang et al. (2021f)
	Down	NSCLC (LUAD): four cell lines (i.a. A549, H1299)	Wu et al. (2020)
	Down	NSCLC tissues and three cell lines (i.a. A549, H1299)	Hu et al. (2020)
	Down	NSCLC (SqCLC) tissues, stage III vs II vs I, four cell lines	Huang et al. (2019a)
	Down	NSCLC tissues	Dong et al. (2016)
	Down	Lung cancer tissues and six cell lines (i.a. A549)	Kong et al. (2015)
	Down	BLCA tissues and four cell lines (i.a. T24)	Yuan et al. (2021)
	Down	BRCA tissues stage I-IV	Dou et al. (2021)
	Down	BRCA tissues, MCF-7 (ER+) and MDA-MB-453 (HER2+)	Zhou et al. (2019)
	Down	HCC tissues	Gao et al. (2021b)
	Down	CeCa tissues	Wang et al. (2022a)
	Down	CeCa tissues	Wang et al. (2021g)
	Down	OVCA tissues	Qiao et al. (2021)

^†,^‡For description see footnote to Table 2